首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到19条相似文献,搜索用时 484 毫秒
1.
本试验用布鲁氏菌强、弱毒株侵染小鼠巨噬细胞RAW264.7,旨在探讨NF-κB信号通路与布鲁氏菌强、弱毒株在胞内生存的关系。采用光滑型牛布鲁氏菌2308、粗糙型牛布鲁氏菌RB51在不同感染复数下侵染小鼠巨噬细胞RAW264.7,侵染0、4、8、24 h后,裂解细胞收集蛋白,Western blotting检测布鲁氏菌对激活NF-κB信号通路的影响。利用不同浓度的NF-κB信号通路抑制剂处理小鼠巨噬细胞RAW264.7,然后用布鲁氏菌在不同感染复数下侵染小鼠巨噬细胞RAW264.7,ELISA试剂盒检测细胞因子TNF-α、IL-1β、IL-6的表达量;同时对胞内菌CFU进行计数。结果显示粗糙型牛布鲁氏菌RB51可以强烈激活NF-κB信号通路,光滑型牛布鲁氏菌2308对其激活作用较弱;同时对NF-κB信号通路的激活具有浓度依赖性,在感染复数为80:1、侵染时间为8 h时光滑型牛布鲁氏菌2308和粗糙型牛布鲁氏菌RB51对NF-κB激活程度最强,且该通路参与产生TNF-α、IL-1β和IL-6;NF-κB信号通路抑制剂BAY11-7082影响布鲁氏菌在胞内的生存。因此,粗糙型牛布鲁氏菌RB51胞内存活与NF-κB信号通路密切相关,为进一步研究布鲁氏菌的胞内致病机制奠定基础,也为布鲁氏菌新型药物的研发、家畜布鲁氏菌病预防和治疗提供科学依据。  相似文献   

2.
试验旨在探究ClpS基因在布鲁氏菌中的作用,分析比较ClpS基因突变对布鲁氏菌毒力的影响。利用同源重组技术,构建布鲁氏菌ClpS基因突变株,通过检测细菌生长曲线、细菌LPS合成能力及其在巨噬细胞内的存活能力和小鼠模型中的毒力,比较亲本株2308和突变株ΔClpS两者之间的差异。结果显示,在相同的培养条件下,亲本株2308和突变株ΔClpS的细菌浓度无明显差异,且两者提取的LPS银染结果基本一致,表明ClpS基因突变不影响布鲁氏菌生长速度,不影响细菌LPS合成;在细胞感染模型中,突变株ΔClpS在感染后72 h的胞内存活能力极显著低于亲本株2308(P<0.01);小鼠感染试验显示,在感染后1周,亲本株2308感染组和突变株ΔClpS感染组小鼠脾脏重量及细菌含量无显著差异,但在感染后4周,突变株ΔClpS感染组的小鼠脾脏细菌含量为103.93 CFU/g脾脏,显著低于亲本株2308(106.68 CFU/g脾脏,P<0.01),且突变株ΔClpS感染组的小鼠脾脏肿胀程度极显著低于亲本株2308(P<0.01)。综上所述,布鲁氏菌ClpS基因突变不影响细菌生长速度及细菌LPS合成能力,但ClpS基因突变可降低布鲁氏菌在小鼠脾脏内的定殖能力。  相似文献   

3.
为研究布鲁菌侵染巨噬细胞过程中,对后者不同分化类型细胞中JAK-STAT6信号通路和细胞因子表达变化的影响,本研究利用小鼠巨噬细胞系RAW264.7,经40 ng/m L的IL-4体外作用24 h将其诱导为M2型巨噬细胞,采用细胞免疫荧光方法,检测M2巨噬细胞极化状态;通过荧光定量PCR(q RT-PCR)方法,检测布鲁菌疫苗株M5侵染不同类型(M0和M2型)巨噬细胞中JAK1、STAT6基因mRNA转录情况;采用ELISA方法检测M5侵染不同类型巨噬细胞上清中IL-10、INF-γ的表达情况。细胞免疫荧光检测结果显示,IL-4诱导24 h后,巨噬细胞表面标志CD206荧光表达量超过90%,表明巨噬细胞极化为M2型;q RT-PCR结果显示,M5侵染M0型巨噬细胞后能够引起JAK1、STAT6 mRNA转录水平持续降低,在24 h和48 h时其转录水平最低,二者差异极显著(p0.01);而M5侵染M2型巨噬细胞后,与未极化组(M0型)相比,JAK1、STAT6的mRNA转录水平增高,同时存在时间差异性,侵染8 h时,二者mRNA转录水平最高,差异极显著(p0.01)。ELISA结果显示,M5侵染巨噬细胞后,极化组(M2型)与未极化组(M0型)巨噬细胞相比,INF-γ的表达量差异不显著(p0.05),而IL-10的表达量上调且在侵染48 h达到最大值,差异显著(p0.05)。上述结果表明,在IL-4的诱导下巨噬细胞可以从未极化的M0型极化为M2型;布鲁菌M5侵染M0型巨噬细胞中JAK1、STAT6的转录水平下调,但上调M2型巨噬细胞JAK1、STAT6的转录水平并促进下游细胞因子IL-10的分泌。本研究为探究布鲁菌引起持续感染的机制研究奠定了基础,同时为布鲁菌病药物靶标开拓了新的研究方向。  相似文献   

4.
本研究旨在阐明金黄色葡萄球菌脂蛋白对M1型小鼠骨髓源巨噬细胞免疫作用的影响,为金黄色葡萄球菌致病性研究提供理论参考。以金黄色葡萄球菌野生株SA113(WT SA113)和SA113 lgt::ermB脂蛋白表达缺失菌株(SA113Δlgt株)体外感染M1型小鼠骨髓源巨噬细胞,分为3组:空白对照组、WT SA113感染组(MOI:3:1)、SA113Δlgt感染组(MOI:3:1)。采用ELISA法检测M1型小鼠骨髓源巨噬细胞中肿瘤坏死因子-α(TNF-α)、白细胞介素1β(IL-1β)、趋化因子(RANTES)和白细胞介素10(IL-10)的水平,实时荧光定量PCR检测Toll样受体2(TLR2)、Toll样受体4(TLR4)和含NLR家族Pyrin域蛋白3(NLRP3)基因的表达,免疫荧光法检测脂蛋白对M1型小鼠骨髓源巨噬细胞吞噬金黄色葡萄球菌作用的影响。结果显示,与空白对照组相比,WT SA113感染组和SA113Δlgt感染组均可显著上调M1型小鼠骨髓源巨噬细胞中TNF-α、RANTES、IL-10分泌量以及WT SA113感染组TLR2、NLRP3基因表达水平(P<0.05),而TLR4基因表达量显著降低(P<0.05);与WT SA113感染组相比,SA113Δlgt感染组M1型小鼠骨髓源巨噬细胞中TNF-α、IL-1β、RANTES、IL-10分泌量以及TLR2(12 h除外)、NLRP3基因表达水平显著降低(P<0.05)。免疫荧光结果显示,M1型巨噬细胞对SA113Δlgt株的吞噬作用显著低于对WT SA113株的吞噬作用(P<0.05)。综上,金黄色葡萄球菌的脂蛋白在M1型小鼠骨髓源巨噬细胞中主要通过激活TLR2和NLRP3受体,诱导细胞因子TNF-α、IL-1β、RANTES和IL-10的产生和释放。  相似文献   

5.
【目的】 试验旨在构建牛种布鲁氏菌S2308的多铜氧化酶(BMCO)基因缺失株,探究缺失株的生长特性及在宿主细胞中的存活能力,并分析BMCO蛋白的结构。【方法】 利用PCR扩增BMCO基因上、下游同源臂和Kan基因,通过融合PCR技术将3段基因进行融合。融合片段与pMD19-T载体连接,制作牛布鲁氏菌S2308感受态细胞,1 800 V电压、400 Ω电阻电转化至牛种布鲁氏菌S2308感受态细胞中,涂布于Kan抗性的布鲁氏菌固体培养基中,筛选挑取阳性菌落,连续培养10代,检测第10代阳性菌落的遗传稳定性和生长变化趋势,将pBBR1MCS-4-BMCO融合质粒电转至能够稳定遗传BMCO基因缺失的牛种布鲁氏菌中,培养筛选阳性菌落。以感染复数(MOI)100分别用亲本株、缺失株、回补株侵染小鼠巨噬细胞RAW264.7,通过平板计数法分别检测3种菌株在细胞内的生存能力。【结果】 试验成功获得片段大小为522、539、1 054 bp的BMCO基因上、下游同源臂和Kan基因;成功构建pMD19-T-BMCO-Kan融合片段重组载体;获得稳定遗传的BMCO基因缺失株,命名为S2308ΔBMCO;成功构建BMCO基因回补株,命名为ΔBMCO::BMCOS2308;缺失株和亲本株表现的生长曲线相同,均在12 h达到对数生长期,30 h进入平台期;侵染小鼠巨噬细胞RWA264.7后,与亲本株S2308相比,S2308ΔBMCO株在胞内的生存能力极显著降低(P<0.01)。生物信息学分析结果表明,BMCO属于疏水蛋白,定位于胞质且含有大量的无规则卷曲、α-螺旋和延伸链,预示该蛋白具有多个结合位点。【结论】 本研究成功构建了布鲁氏菌BMCO基因的缺失株和回补株,BMCO基因的缺失不影响其生长性能,但其在宿主细胞内的存活能力显著性降低,初步分析了BMCO蛋白的结构,为后续布鲁氏菌分泌蛋白的功能研究奠定基础。  相似文献   

6.
为研究布鲁氏菌LPS对巨噬细胞中NLRP3炎症小体的影响,本试验提取布鲁氏菌2308、RB51和△WbkA的LPS,以不同浓度与小鼠巨噬细胞相互作用,荧光定量PCR检测其对NLRP3、ASC、Caspase1、IL1-β、IL18转录水平的影响。结果显示RB51LPS和△WbkA LPS上调NLRP3炎症小体相关基因的转录水平,且呈浓度依赖性,而浓度对2308LPS调节NLRP3炎症小体相关基因转录的作用不大;且同一浓度下,RB51LPS和2308LPS比△WbkA LPS更好的调节Caspase1、IL1-β、IL18的转录水平。  相似文献   

7.
为探究Ⅳ型分泌系统在布鲁氏菌(Brucella)感染过程中的作用,深入了解布鲁氏菌Ⅳ型分泌系统在疫苗开发中的潜力,本研究以牛种布鲁氏菌A19疫苗株为研究对象,使用A19 VirB启动子缺失株感染小鼠树突状细胞(DCs),通过菌落计数(CFU)评估Ⅳ型分泌系统对布鲁氏菌黏附侵袭及胞内生存的影响,同时对感染的细胞进行RNA和总蛋白的提取,分别通过实时荧光定量PCR和Western blotting检测自噬基因Beclin-1的转录和表达情况;收集感染后的细胞上清液,利用ELISA检测炎症因子白细胞介素-6(IL-6)和IL-10的分泌水平。黏附侵袭结果显示,布鲁氏菌VirB启动子缺失株与亲本株A19的黏附侵袭水平无显著差异(P>0.05);胞内生存试验发现,感染的4 h,布鲁氏菌VirB启动子缺失株的胞内存活能力显著低于亲本株A19(P<0.05),感染后0、24和48 h极显著低于亲本株A19(P<0.01);实时荧光定量PCR和Western blotting结果显示,感染后4、8和12 h,布鲁氏菌VirB启动子缺失株刺激细胞产生Beclin-1的水平极显著高于亲本株A19(P<0.01);ELISA结果显示,感染后8和12 h,布鲁氏菌VirB启动子缺失株刺激细胞产生IL-6的水平显著高于亲本株A19(P<0.05),而在感染后8和12 h,布鲁氏菌VirB启动子缺失株刺激细胞分泌IL-10的水平显著低于亲本株A19(P<0.05),感染24 h时极显著低于亲本株A19(P<0.01)。综上所述,当VirB启动子缺失后,布鲁氏菌对DCs的黏附侵袭能力并未明显改变,但显著降低了布鲁氏菌在DCs内的存活能力,提升了DCs的自噬水平,促进了DCs IL-6的分泌,抑制了IL-10的分泌。本研究初步探究了布鲁氏菌Ⅳ型分泌系统在感染DCs过程中的生物学作用,为后续布鲁氏菌疫苗改造研究奠定了理论基础。  相似文献   

8.
为检测国内外已有的布鲁氏菌疫苗株S19、M5、S2和RB51的胞内存活力、毒力、免疫保护力以及抗体消长水平,将上述4种疫苗株,分别以100:1的MOI侵染小鼠巨噬细胞,结果发现RB51的胞内存活力最强;以1×10~6 CFU/只免疫昆明小白鼠,测定各疫苗株在小鼠脾脏中的定居力,结果发现M5的定居力最强;待疫苗株在小鼠体内被清除后,以1×10~5 CFU/只腹腔接种2308毒株,进行攻毒试验,检测各疫苗株的保护力,结果发现M5的保护效果最好;免疫后连续10周采集血清,用ELISA检测血清中的Ig G滴度、IFN-γ的表达水平及抗体消长水平,结果发现S2、M5组的Ig G水平高于其他组,而各组间的IFN-γ水平差异不显著(P0.05);分别用虎红平板凝集试验(RBPT)和标准试管凝集试验(SAT)检测血清凝集状况,结果发现S2、S19组的抗体持续时间较长;剖检各疫苗株对小鼠脾脏、肝脏、肾脏等组织引起的病理学变化,结果发现M5引起的病变程度最强。  相似文献   

9.
为了构建牛布鲁菌S2308(简称S2308)的铁转录调控因子rirA基因突变株(S2308ΔrirA),探讨该基因对自身生长的影响以及其对不同类型细胞黏附侵袭和胞内繁殖的作用。利用同源重组和抗性替换的方法,以卡那抗性基因替换rirA基因,获得突变株S2308ΔrirA。将亲本株S2308、疫苗株RB51和突变株S2308ΔrirA在相同营养条件下培养,观察其振荡培养时的生长变化趋势和静置培养时的聚集状态。将各菌株侵染人胚胎滋养层细胞(HPT-8)和小鼠巨噬细胞(RAW264.7),分别检测其黏附侵袭能力和胞内生存能力。结果显示,成功获得了布鲁菌rirA基因突变株且10代内未发生回复性突变;与亲本株相比,S2308ΔrirA在相同体外培养条件下其生长趋势未发生明显改变,且其凝集状态与亲本株类似;黏附侵袭试验显示,S2308ΔrirA对HPT-8细胞的黏附侵袭能力显著强于亲本株,而其对RAW264.7的黏附侵袭能力在一定程度上弱于亲本株;布鲁菌胞内生存试验发现,布鲁菌侵染HPT-8细胞24h后,其胞内细菌数量显著升高,而侵染巨噬细胞24h后,S2308ΔrirA的繁殖能力明显低于亲本株。这些结果表明,铁转录调控因子rirA基因参与了布鲁菌胞内寄生的过程,并与菌株的毒力强弱存在密切联系。  相似文献   

10.
猪舍细颗粒物促进猪原代肺泡巨噬细胞向M1极化   总被引:1,自引:1,他引:0  
旨在研究猪舍细颗粒物(PM2.5)对猪原代肺泡巨噬细胞(PAMs)精氨酸代谢、炎症因子表达和极化标志物表达的影响。利用支气管肺泡灌洗方法,体外分离PAMs,细胞纯化后,利用Diff-quik染色和F4/80标记鉴定PAMs,并测定细胞活力。将纯化培养的PAMs分为对照组和PM2.5处理组(50 μg·mL-1),继续培养4、8和12 h,测定细胞活力,收集细胞上清测定一氧化氮(NO)的含量,裂解PAMs测定精氨酸酶的活性,并采用RT-PCR检测PAMs炎症因子IL-1β、TNF-αIL-10以及M1、M2型巨噬细胞标志物CD80和CD206的表达水平。结果显示,通过支气管肺泡灌洗方法成功分离培养了PAMs,并发现PAMs的细胞活力随着培养时间的延长逐渐降低(P<0.05)。PM2.5处理PAMs,显著提高了细胞上清中NO含量(P<0.05),显著降低了细胞精氨酸酶的活性(P<0.01),并显著提高了细胞炎症因子IL-1β和TNF-α mRNA表达水平(P<0.01),降低了IL-10 mRNA表达水平(P<0.05)。另外,PM2.5处理PAMs早期,显著提高了CD80 mRNA表达水平(P<0.01),在后期显著降低CD206 mRNA表达水平(P<0.01)。综上表明,猪舍PM2.5促进了PAMs向M1表型极化,促进了炎症的发展。  相似文献   

11.
Brucella abortus strain RB51 is an attenuated rough strain, currently being used as the official live vaccine for bovine brucellosis in the USA and several other countries. In strain RB51, the wboA gene, encoding a glycosyltransferase required for the O-side chain synthesis, is disrupted by an IS711 element. Recently, we have demonstrated that strain RB51WboA, RB51 complemented with a functional wboA gene, remains rough but expresses low quantities of O-side chain in the cytoplasm. Mice vaccinated with strain RB51WboA develop greatly enhanced resistance against challenge with B. abortus virulent strain 2308. We have also demonstrated that overexpression of Cu/Zn superoxide dismutase (SOD) in strain RB51 (RB51SOD) significantly increases its vaccine efficacy against strain 2308 challenge. In this study, we constructed a new recombinant strain, RB51SOD/WboA, that over expresses SOD with simultaneous expression of O-side chain in the cytoplasm. We tested the vaccine potential of strains RB51SOD, RB51WboA, RB51SOD/WboA against challenge with virulent Brucella melitensis 16M and B. abortus 2308 in mice. In comparison with strain RB51, strain RB51SOD induced better protection against strain 2308, but not strain 16M, challenge. Similar to strain RB51WboA, vaccination with strain RB51SOD/WboA resulted in complete protection of the mice from infection with strain 2308. When challenged with strain 16M, mice vaccinated with either strain RB51WboA or strain RB51SOD/WboA were significantly better protected than those vaccinated with strain RB51 or RB51SOD. These results suggest that strains RB51WboA and RB51SOD/WboA are good vaccine candidates for inducing enhanced protection against B. melitensis infection.  相似文献   

12.
Brucella is responsible for one of the major worldwide zoonoses. Over the last century, several vaccines have been used against brucellosis. Among these, the rough vaccine Brucella abortus RB51 was introduced with the idea that it would not interfere with the diagnosis of brucellosis. Recently, RB51 has been isolated from milk and vaginal exudates from vaccinated cows, thus raising the possibility of extensive bacterial replication in these animals. We hypothesized that shedding of RB51 might be related to a change in its intracellular cell cycle. Therefore, we have compared the intracellular trafficking in CHO cells of the virulent B. abortus 2308 and two RB51 strains, the vaccinal strain and the one isolated from cow milk. Both RB51 strains were transiently observed in phagosomes characterized by the presence of the early endosomal marker EEA1 and then were found in cathepsin D-enriched lysosomal compartments, in which they eventually underwent degradation at later post-infection times. In contrast, the virulent 2308 strain replicated within the endoplasmic reticulum. These results suggest that a change in intracellular trafficking cannot account for Brucella shedding in adult vaccinated cows.  相似文献   

13.
Neospora caninum, an obligate intracellular protozoan parasite, is the causative agent of bovine neosporosis, an important disease affecting the reproductive performance of cattle worldwide. Currently there is no effective vaccine available to prevent N. caninum infection in cattle. In this study, we examined the feasibility of developing a live, recombinant N. caninum vaccine using Brucella abortus vaccine strain RB51 as the expression and delivery vector. We generated two recombinant RB51 strains each expressing SRS2 (RB51/SRS2) or GRA7 (RB51/GRA7) antigens of N. caninum. BALB/c mice immunized by single intraperitoneal inoculation of the recombinant RB51 strains developed IgG antibodies specific to the respective N. caninum antigen. In vitro stimulation of splenocytes from the vaccinated mice with specific antigen resulted in the production of interferon-gamma, but not IL-5 or IL-10, suggesting the development of a Th1 type immune response. Upon challenge with N. caninum tachyzoites, mice vaccinated with strain RB51/SRS2, but not RB51/GRA7, showed significant resistance to cerebral infection when compared to the RB51 vaccinated mice, as determined by the tissue parasite load using a real-time quantitative TaqMan assay. Interestingly, mice vaccinated with either strain RB51 or RB51/GRA7 also contained significantly lower parasite burden in their brains compared to those inoculated with saline. Mice vaccinated with strain RB51/SRS2 or RB51/GRA7 were protected to the same extent as the strain RB51 vaccinated mice against challenge with B. abortus virulent strain 2308. These results suggest that a recombinant RB51 strain expressing an appropriate protective antigen(s), such as SRS2 of N. caninum, can confer protection against both neosporosis and brucellosis.  相似文献   

14.
Biological properties of RB51; a stable rough strain of Brucella abortus   总被引:27,自引:0,他引:27  
A rifampin-resistant mutant of Brucella abortus, designated RB51, was derived by repeated passage of strain 2308 on Trypticase soy supplemented with 1.5% agar and varying concentrations rifampin or penicillin. The RB51 colonies absorbed crystal violet and RB51 cell suspensions autoagglutinated, indicating a rough type colonial morphology for this strain. No O-chain component was detected in lipopolysaccharide (LPS) extracted from RB51 on SDS-PAGE gels stained with silver. Western blot analysis with the monoclonal antibody BRU 38, which is specific for the perosamine homopolymer O-chain of smooth Brucella LPS, indicated that the LPS of RB51 is highly deficient in O-chain when compared with the parenteral smooth strain 2308 or rough strain 45/20. Biochemically, RB51 resembles parental strain 2308 in its ability to utilize erythritol. Intraperitoneal inoculation of RB51 into mice results in a splenic colonization which is cleared within four weeks post infection. RB51 does not revert to smooth colony morphology upon passage in vivo (mice) or in vitro. Mice infected with RB51 produce antibodies against B. abortus antigens including class 2 and 3 outer membrane proteins but not against the O-chain. Furthermore, rabbits, goats and cattle hyperimmunized with sonicates of RB51 develop antibodies to B. abortus cellular antigens but do not develop antibodies specific for the O-chain. Immunization of mice with 1 x 10(8) viable RB51 organisms confers significant protection against challenge with virulent B. abortus strain 2308.  相似文献   

15.
By the infection of Brucella virulent strain and attenuated strain in mice macrophage RAW264.7,the assay was aimed to explore the relationship between NF-κB signaling pathways and Brucella virulent strain and attenuated strain in intracellular survival.Use different MOI Brucella (2308,RB51,16M and M5) to infect mice macrophage RAW264.7,after 0,4,8 and 24 h infected,cracking cell and collecting supernatant,we detected the effect of Brucella on activation of NF-κB signaling pathway by Western blotting.Different concentrations of NF-κB signaling pathway inhibitor were incubated with mice macrophage RAW264.7,with different multiplicities of infection (MOI) of Brucella infecting cells,ELISA kits to detect the expressions of TNF-α,IL-1β and IL-6 cytokine;At the same time,count the number of intracellular bacteria of CFU.The results showed that rough cattle Brucella strains RB51 could strongly activate NF-κB signaling pathway,smooth cattle Brucella strains 2308 was weak in the activation;At the same time,the activation of NF-κB signaling pathway was concentration dependent.When the MOI was 80,infection time was 8 h,NF-κB activation degrees of rough cattle Brucella strains RB51 and smooth cattle Brucella strains 2308 were the strongest,and this pathway was involved in producing TNF-α and IL-6;NF-κB signaling pathway inhibitor BAY11-7082 affected Brucella intracellular survival.So rough cattle Brucella strains RB51 intracellular survival and NF-κB signaling pathway activity were closely related.The results laid the foundation for the further study of Brucella intracellular pathogenesis,also provided scientific basis for the research of new drugs to Brucella,and prevention and treatment of brucellosis.  相似文献   

16.
This study determined if murine interleukin-12 (IL-12) would influence immunity in mice vaccinated with live or killed Brucella abortus strain RB51 (SRB51). Mice received live or gamma-irradiated SRB51 bacteria alone, or with IL-12 (0.5 or 1.0 microg, 2x or 3x), whereas other mice received saline or IL-12 alone. Post-vaccination antibody responses to live or killed SRB51 and clearance of live SRB51 from splenic tissue were not influenced by IL-12 treatments. Mice were challenged at 12 weeks with 4 x 10(4) cfu of B. abortus strain 2308 (S2308) and were euthanized 2 weeks later. The highest IL-12 treatment increased (P < 0.05) post-challenge antibody responses when co-administered with killed SRB51. Co-administration of 1.0 microg of IL-12 with live SRB51, but not killed SRB51, reduced (P < 0.05) S2308 colonization of splenic tissues. Our data suggest that although IL-12 may augment protective immunity induced by live SRB51, it does not influence protection induced by vaccination with killed SRB51.  相似文献   

17.
This study was designed to determine if a single 0.5 microg administration of recombinant murine interleukin-12 (IL-12) would influence immune responses of mice vaccinated with live or killed Brucella abortus strain RB51 (SRB51). Mice were vaccinated intraperitoneally with 5 x 10(8) cfu of live or gamma-irradiated SRB51 bacteria alone, or in combination with 0.5 microg of IL-12. Control mice received saline or 0.5 microg of IL-12. Serologic responses and spleen weights after vaccination were greater in mice vaccinated with live SRB51 when compared to mice receiving killed SRB51 or control treatments. Administration of a single dose of IL-12 as a vaccine adjuvant did not influence immune responses, clearance of live SRB51, or resistance against B. abortus strain 2308 (S2308) challenge. The results of this study suggest that a single administration of 0.5 microg of IL-12 at the time of vaccination does not have significant adjuvant effects on vaccine-induced immune responses against live or killed Brucella.  相似文献   

18.
Brucella abortus strain RB51, a rough mutant of the B. abortus 2308 virulent strain, was recently approved in the United States as the official vaccine for brucellosis in cattle. Following recent evidence of unauthorized use of RB51 vaccine in Italy, where the use of vaccines for brucellosis is no longer allowed, the suitability of an RB51-specific polymerase chain reaction assay for identifying the RB51 strain among Brucella field isolates from cattle in Italy was investigated. The oligonucleotide primers used in this study, belonging to a six-primer cocktail for Brucella species previously described by other authors, allowed the amplification of a 364-base pair (bp) fragment specific for RB51 and its parent strain 2308, and a 498-bp product specific for B. abortus. In addition, unresolved bands ranging from 600 to 700 bp were observed from RB51 strain. Brucella abortus biovars 1, 2 and 4 have only one specific sensitive 498-bp band. The B. abortus biovars 3, 5 and 6 did not give any signal. The 498-bp product from a reference Brucella strain was sequenced and submitted to EMBL with the accession number AJ271969 while the 364-bp fragment from RB51 strain was submitted to EMBL database with accession number AJ271968. The sequence studies confirmed the specificity of the detected fragments. No amplification was obtained by testing DNA from strains antigenically related to Brucella, such as Yersinia enterocolitica O:9, Escherichia coli O:157, Salmonella urbana and Pasteurella multocida. The results of this study indicate that this technique, in combination with specific serological tests, could be a useful diagnostic method to verify the use of RB51 vaccine and can contribute to the creation of a databank of circulating strains.  相似文献   

19.
To characterize the optimal aerosol dosage of Brucella abortus strain 2308 (S2308) and B. melitensis (S16M) in a laboratory animal model of brucellosis, dosages of 10(3)-10(10) colony forming units (CFU) were nebulized to mice. Although tissue weights were minimally influenced, total CFU per tissues increased beginning at 10(6)-10(7) CFU dosages, with 10(9) CFU appearing to be an optimal dosage for S16M or S2308 aerosol delivery. At 12 weeks after vaccination with 10(7) CFU of B. abortus strain RB51 (SRB51) or saline (control), mice were challenged intraperitoneally (i.p.) (6.4 x 10(4) CFU) or via aerosol (1.76 x 10(9) CFU) with S2308. Mice vaccinated with SRB51 had reduced (P < 0.05) splenic, liver and lung colonization (total CFU and CFU/g) after i.p. challenge with S2308 as compared with control mice after i.p. S2308 challenge. Control and SRB51-vaccinated mice did not differ (P > 0.05) in splenic, liver or lung colonization after aerosol S2308 challenge. Failure to demonstrate vaccine protection was not because of a high aerosol challenge dosage as colonization of spleen and liver tissues was lower (P < 0.05) after aerosol challenge when compared with control mice after i.p. S2308 challenge.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号